JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (33) Citing Articles via Google Scholar Google Scholar Articles by Debaveye, Y. A. Articles by Van den Berghe, G. H. Search for Related Content PubMed PubMed Citation Articles by Debaveye, Y. A. Articles by Van den Berghe, G. H. Related Collections Cardiovascular Heart Pharmacology Critical Care

---

CRITICAL CARE AND TRAUMA

Is There Still a Place for Dopamine in the Modern Intensive Care Unit?

Department of Intensive Care Medicine, Catholic University of Leuven, Leuven, Belgium

Address correspondence and reprint requests to Greet Van den Berghe, MD, PhD, Department of Intensive Care Medicine, Catholic University of Leuven, B-3000 Leuven, Belgium. Address e-mail to greta.vandenberghe{at}med.kuleuven.ac.be

For many years, dopamine was considered an essential drug in the intensive care unit (ICU) for its cardiovascular effects and, even more, for its supposedly protective effects on renal function and splanchnic mucosal perfusion. There is now ample scientific evidence that low dose dopamine is ineffective for prevention and treatment of acute renal failure and for protection of the gut. Until recently, low-dose dopamine was considered to be relatively free of side effects. However, it is now clear that low-dose dopamine, besides not achieving the preset goal of organ protection, may also be deleterious because it can induce renal failure in normo- and hypovolemic patients. Furthermore, dopamine may cause harm by impairing mucosal blood flow and by aggravating reduced gastric motility. Dopamine also suppresses the secretion and function of anterior pituitary hormones, thereby aggravating catabolism and cellular immune dysfunction and inducing central hypothyroidism. In addition, dopamine blunts the ventilatory drive, increasing the risk of respiratory failure in patients who are being weaned from mechanical ventilation. We conclude that there is no longer a place for low-dose dopamine in the ICU and that, in view of its side effects, its extended use as a vasopressor may also be questioned.

This article has been cited by other articles:

				S. Herget-Rosenthal, F. Saner, and L. S. Chawla Approach to Hemodynamic Shock and Vasopressors Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 546 - 553. [Full Text] [PDF]

				W. C. Oliver Jr, G. A. Nuttall, K. J. Cherry, P. A. Decker, T. Bower, and M. H. Ereth A Comparison of Fenoldopam with Dopamine and Sodium Nitroprusside in Patients Undergoing Cross-Clamping of the Abdominal Aorta Anesth. Analg., October 1, 2006; 103(4): 833 - 840. [Abstract] [Full Text] [PDF]

				M. B. Vroom An overview of inotropic agents. Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2006; 10(3): 246 - 252. [Abstract] [PDF]

				D. J. Kutsogiannis, G. Pagliarello, C. Doig, H. Ross, and S. D. Shemie Medical management to optimize donor organ potential: review of the literature: [Traitement medical pour optimaliser le potentiel de don d'organe : une revue documentaire]. Can J Anesth, August 1, 2006; 53(8): 820 - 830. [Abstract] [Full Text] [PDF]

				G. Manoharan, N. H.J. Pijls, N. Lameire, K. Verhamme, G. R. Heyndrickx, E. Barbato, W. Wijns, J. Madaric, X. Tielbeele, J. Bartunek, et al. Assessment of Renal Flow and Flow Reserve in Humans J. Am. Coll. Cardiol., February 7, 2006; 47(3): 620 - 625. [Abstract] [Full Text] [PDF]

				A C Fry and K Farrington Management of acute renal failure Postgrad. Med. J., February 1, 2006; 82(964): 106 - 116. [Abstract] [Full Text] [PDF]

				D. Jones and R. Bellomo Renal-Dose Dopamine: From Hypothesis to Paradigm to Dogma to Myth and, Finally, Superstition? J Intensive Care Med, July 1, 2005; 20(4): 199 - 211. [Abstract] [PDF]

				J. O. Friedrich, N. Adhikari, M. S. Herridge, and J. Beyene Meta-Analysis: Low-Dose Dopamine Increases Urine Output but Does Not Prevent Renal Dysfunction or Death Ann Intern Med, April 5, 2005; 142(7): 510 - 524. [Abstract] [Full Text] [PDF]

				F. B. Plotz and I. Prins Small-Dose Dopamine in Critically Ill Infants and Children Anesth. Analg., October 1, 2004; 99(4): 1262 - 1263. [Full Text] [PDF]

				S. Garwood Renal Insufficiency After Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2004; 8(3): 227 - 241. [Abstract] [PDF]

				E. A. Hessel II Abdominal Organ Injury After Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2004; 8(3): 243 - 263. [Abstract] [PDF]

				S. G. Raja, Y. A. Debaveye, and G. H. Van den Berghe Let Us Not Displace Small-Dose Dopamine from the Modern ICU So Soon * Response Anesth. Analg., September 1, 2004; 99(3): 956 - 957. [Full Text] [PDF]

Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999